Actively Recruiting
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
Led by MSD Italia S.r.l. · Updated on 2025-01-14
600
Participants Needed
25
Research Sites
52 weeks
Total Duration
On this page
Sponsors
M
MSD Italia S.r.l.
Lead Sponsor
Y
YGHEA, CRO Division of Ecol Studio spa
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a non-interventional, retrospective observational study to improve knowledge regarding the diagnosis and treatments of patients who have/had non-small cell lung cancer (NSCLC), either early stage (stage I-II).
CONDITIONS
Official Title
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with stage I-III NSCLC who have received curative surgery or radiotherapy between January 2018 and June 2019 with available follow-up through January 2021
- Adult patients (aged 218 years) at the moment of diagnosis
- Patients (or their legally acceptable representatives) must have signed and dated the Informed Consent form; privacy Form (ICF). In case of deceased or untraceable patient the investigator before collecting data shall demonstrate and report all necessary measures adopted to contact the patient.
You will not qualify if you...
- Patients without availability of medical charts or information required
- Enrollment in studies imposing a specific patient's management strategy which does not correspond to the site's normal clinical practice.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 25 locations
1
IRCCS Casa di sollievo dalla sofferenza
San Giovanni Rotondo, FG, Italy
Not Yet Recruiting
2
ASST degli Spedali Civili di Brescia
Brescia, Italy
Not Yet Recruiting
3
Gemelli Molise
Campobasso, Italy
Not Yet Recruiting
4
Humanitas Istituto Clinico Catanese
Catania, Italy
Not Yet Recruiting
5
Policlinico Rodolico
Catania, Italy
Not Yet Recruiting
6
AOU Careggi
Florence, Italy
Actively Recruiting
7
IRCCS Policlinico S. Martino
Genova, Italy
Actively Recruiting
8
AO Papardo
Messina, Italy
Not Yet Recruiting
9
IRCCS Ospedale San Raffaele
Milan, Italy
Actively Recruiting
10
Istituto Clinico Humanitas
Milan, Italy
Actively Recruiting
11
Istituto Nazionale dei Tumori - Fondazione IRCCS
Milan, Italy
Not Yet Recruiting
12
AOU dei Colli - Monaldi
Naples, Italy
Not Yet Recruiting
13
AOU Vanvitelli
Naples, Italy
Actively Recruiting
14
A.O.U. Maggiore della Carità di Novara
Novara, Italy
Actively Recruiting
15
IOV - Istituto Oncologico veneto - IRCCS
Padova, Italy
Not Yet Recruiting
16
AOUP Policlinico Giaccone
Palermo, Italy
Not Yet Recruiting
17
Azienda Ospedaliera Perugia - Ospedale S. Maria della MIsericordia
Perugia, Italy
Not Yet Recruiting
18
Azienda USL Toscana Centro - Ospedale san Jacopo
Pistoia, Italy
Actively Recruiting
19
Centro di Riferimento Oncologico IRCCS
Pordenone, Italy
Not Yet Recruiting
20
Azienda Ospedaliera Regionale San Carlo di Potenza
Potenza, Italy
Not Yet Recruiting
21
AUSL Romagna Ospedale Santa Maria delle Croci Ravenna
Ravenna, Italy
Not Yet Recruiting
22
IRCCS AUSL Reggio Emilia
Reggio Emilia, Italy
Not Yet Recruiting
23
Fondazione Policlinico Universitario "A. Gemelli"
Roma, Italy
Not Yet Recruiting
24
ASST dei Sette Laghi
Varese, Italy
Not Yet Recruiting
25
AOUI Verona
Verona, Italy
Not Yet Recruiting
Research Team
D
Daniele Righi, PM
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here